Concepedia

David A. Erickson

DA

Statistics

Publications

10

Citations

505

H-Index

10

Active since

1981

Affiliations

Boehringer Ingelheim (United States)(Current)

Medical College of Wisconsin

Covance (United States)

David A. Erickson is an author at Boehringer Ingelheim (United States) specializing in pharmacology, medicine, and metabolism.

Top concepts

Publications per year

1981–2007

10

Publications

10

Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450

David A. Erickson, Gary Mather, W. Trager et al. · Drug Metabolism and Disposition · 1999 · 276 citations

Nevirapine induces both CYP3A4 and CYP2B6 metabolic pathways

Michael Lamson, Thomas R. MacGregor, P S Riska et al. · Clinical Pharmacology & Therapeutics · 1999 · 45 citations

, , +3

The effect of piperonyl butoxide on hepatic cytochrome P-450-dependent monooxygenase activities in rainbow trout (Salmo gairdneri)

David A. Erickson, Mark S. Goodrich, John J. Lech · Toxicology and Applied Pharmacology · 1988 · 35 citations

, , +12

Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 7. 8-Arylethyldipyridodiazepinones as Potent Broad-Spectrum Inhibitors of Wild-Type and Mutant Enzymes

Janice M. Klunder, MaryAnn Hoermann, Charles L. Cywin et al. · Journal of Medicinal Chemistry · 1998 · 34 citations · Full text

, , +17

Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 8. 8-Aryloxymethyl- and 8-Arylthiomethyldipyridodiazepinones

Charles L. Cywin, Janice M. Klunder, MaryAnn Hoermann et al. · Journal of Medicinal Chemistry · 1998 · 32 citations · Full text

1–5 of 10